eagle-i
 
University of Hawaii at ManoaUniversity of Hawaii at Manoa
See it in Search
This page is a preview of the following resource. Continue onto eagle-i search using the button on the right to see the full record.

Randomized phase II trial of panitumumab, erlotinib and gemcitabine vs. erlotinib and gemcitabine in patients with untreated, metastatic pancreatic adenocarcinoma

eagle-i ID

http://hawaii.eagle-i.net/i/00000130-dda8-39ed-9953-50a980000000

Resource Type

  1. Clinical trial

Properties

  1. ClinicalTrials.gov url
    http://www.clinicaltrials.gov/ct2/show/NCT00550836?term=N064B&rank=1
  2. Intervention
    Panitumumab
  3. Intervention
    Gemcitabine
  4. Intervention
    Erlotinib
  5. Intervention
    Antineoplastic combined chemotherapy
  6. Resource Description
    This randomized phase II trial is studying how well giving panitumumab together with gemcitabine and erlotinib works compared to giving gemcitabine and erlotinib alone in treating patients with metastatic pancreatic cancer.
  7. Contact
    Berenberg, Jeffrey
  8. PI
    Berenberg, Jeffrey
  9. Topic
    pancreatic cancer
  10. Funded by
    North Central Cancer Treatment Group
  11. Phase
    Phase 2 clinical trial
  12. Performed by
    Clinical Protocol & Data Management Shared Resource
 
RDFRDF
 
Inferred Types from the eagle-i Ontology (What is an ontology?)
Provenance Metadata About This Resource Record
Copyright © 2016 by the President and Fellows of Harvard College
The eagle-i Consortium is supported by NIH Grant #5U24RR029825-02 / Copyright 2016